Now I have all the information needed. The model scores confirm what's clear from the paper itself: the weaknesses are decisive and overwhelming, despite the genuine strengths in cohort curation.

Let me write the final review.

---

## Summary

This paper introduces MOCHA, a curated collection of 10 multi-subject spatially resolved transcriptomics (SRT) cohorts, each with expert pathologist spatial domain annotations. The authors correctly identify a real gap — existing SRT repositories lack multi-sample datasets with standardized expert annotations for benchmarking integration methods — and assemble a diverse set of cohorts spanning multiple tissue types, technologies, and scales.

## Strengths

- **Diverse and well-selected cohort collection.** The 10 cohorts (Table 1) cover breast, colorectal, kidney, lung, brain, and olfactory bulb tissues, include both 10x Visium and ST platforms, and range from 3 to 94 subjects. This breadth makes MOCHA a potentially useful benchmarking resource.
- **Valuable central proposition.** Pairing every sample with pathologist-derived spatial domain labels addresses a genuine need, since existing repositories (SORC, Aquila, SODB, STOmicsDB, SpatialDB) store raw data but lack standardized expert annotations across multiple subjects.
- **Clearly identified gap.** The paper articulates well (lines 16–18) why multi-subject datasets with annotations are a bottleneck for method development in multi-sample integration.

## Weaknesses

### Fatal

- **No experiments, evaluation, or demonstration of utility.** The paper claims MOCHA "enables evaluation of domain delineation and representation learning in multi-sample contexts" (lines 24–25) but never actually runs any method, reports any clustering metric, computes inter-annotator agreement, or provides any baseline results. A reader cannot tell whether the annotations are consistent enough to serve as ground truth or whether existing methods produce meaningful results on these cohorts. The paper has no Results, Experiments, or Discussion section.

- **No data access information.** The paper states MOCHA "is released in formats readily usable with Python and R" (lines 24–25) but provides no URL, DOI, repository name, GitHub link, or any means to access the resource. For a dataset paper, this is fatal — a reader cannot evaluate, use, or cite the resource.

- **Structurally incomplete.** The paper has no Results, Discussion, Limitations, or Conclusion section and ends abruptly after Section 4 (line 91). A dataset paper should at minimum characterize its data, validate its annotations, and discuss caveats.

### Major

- **Annotation process critically underspecified.** The paper states expert annotations exist (line 28) and mentions four broad categories — immune, stroma, tumor, normal (lines 90–91) — but provides no information about how many pathologists produced them, the annotation protocol, quality control measures, inter-annotator agreement, the label taxonomy per cohort, or how many spots fall into each category. These details are essential for a resource whose primary contribution is expert annotations.

- **Sections 3 and 4 are generic tutorial content.** Section 3 (lines 57–75) describes standard preprocessing pipelines (library-size normalization, HVG selection, Harmony, Crescendo) in a textbook manner without linking them to anything MOCHA specifically provides. Section 4 (lines 76–91) lists three existing methods (BayeSMART, BASS, STAGATE) with a generic summary table. Together these occupy roughly half the non-reference text yet describe general knowledge rather than MOCHA-specific contributions.

### Minor

- **Abstract overclaims.** The abstract promises "standardized data organization, efficient storage formats for large-scale processing, and protocols for handling batch effects" (lines 10–11), but none of these are described in the body. Section 3 only surveys existing methods generically.

### Trivial

None.

## Nice-to-Haves

- Run at least one of the three listed methods (BASS, STAGATE, BayeSMART) on the MOCHA cohorts and report standard clustering metrics (ARI, NMI) against pathologist annotations to demonstrate the resource's utility and provide baselines for future work.
- Add a systematic comparison table showing what existing repositories (SORC, Aquila, SODB, STOmicsDB, SpatialDB) offer versus what MOCHA adds.
- Report per-cohort annotation statistics: number of categories, number of spots per category, annotation agreement metrics.
- Condense Sections 3 and 4 into a brief background paragraph.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **Figure 1 described three times (lines 51, 53, 55):** This is a PDF-parser artifact where the figure caption was extracted multiple times. The original submission does not have this issue.
- **"No comparison table with existing repositories":** While useful, this is a nice-to-have rather than a structural weakness. The paper does cite these repositories in the introduction.
- **"Strengthening the Paper on Its Own Terms" section from the harsh critic:** These are constructive suggestions, not weaknesses. All relevant points have been moved to Nice-to-Haves.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

The core idea — a multi-sample SRT resource with expert annotations — fills a genuine gap, but the paper in its current form is incomplete. To be publishable, the authors need to (a) add experimental validation by running existing methods on the cohorts and reporting metrics against the annotations, (b) provide a URL/DOI for data access, (c) supply detailed annotation methodology and quality metrics, and (d) replace the generic tutorial content with MOCHA-specific data characterization and analysis. These are substantive additions, not minor revisions.

## Score and Decision

The paper identifies a real bottleneck and selects a diverse, well-motivated set of cohorts. However, the combination of (1) no experimental evaluation whatsoever, (2) no data access information, (3) a structurally incomplete paper lacking results/discussion/conclusion, (4) critically underspecified annotation details, and (5) half the paper consumed by generic tutorial material makes this fundamentally unsuitable for publication in its current form. The resource may become valuable once the authors complete the paper with experiments, access details, annotation characterization, and proper structure.

MY FINAL SCORE: <score>3</score>
MY FINAL DECISION: <decision>Reject</decision>